CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Overview
NYSEARCA:CANF - US13471N3008 - ADR
CANF Key Statistics, Chart & Performance
The current stock price of CANF is 0.6314 USD. In the past month the price decreased by -3.82%. In the past year, price decreased by -71.56%.
CANF Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About CANF
Company Profile
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Company Info
CAN FITE BIOPHARMA LTD-ADR
10 Bareket Street, Kiryat Matalon, P.O. Box 7537
Petah Tikva 4951778 IL
CEO: Pnina Fishman
Employees: 5
Phone: 97239241114
CAN FITE BIOPHARMA LTD-ADR / CANF FAQ
What is the stock price of CAN FITE BIOPHARMA LTD-ADR today?
The current stock price of CANF is 0.6314 USD. The price decreased by -4.84% in the last trading session.
What is the ticker symbol for CAN FITE BIOPHARMA LTD-ADR stock?
The exchange symbol of CAN FITE BIOPHARMA LTD-ADR is CANF and it is listed on the NYSE Arca exchange.
On which exchange is CANF stock listed?
CANF stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for CAN FITE BIOPHARMA LTD-ADR stock?
7 analysts have analysed CANF and the average price target is 6.7 USD. This implies a price increase of 960.87% is expected in the next year compared to the current price of 0.6314. Check the CAN FITE BIOPHARMA LTD-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CAN FITE BIOPHARMA LTD-ADR worth?
CAN FITE BIOPHARMA LTD-ADR (CANF) has a market capitalization of 8.39M USD. This makes CANF a Nano Cap stock.
How many employees does CAN FITE BIOPHARMA LTD-ADR have?
CAN FITE BIOPHARMA LTD-ADR (CANF) currently has 5 employees.
What are the support and resistance levels for CAN FITE BIOPHARMA LTD-ADR (CANF) stock?
CAN FITE BIOPHARMA LTD-ADR (CANF) has a resistance level at 0.65. Check the full technical report for a detailed analysis of CANF support and resistance levels.
Should I buy CAN FITE BIOPHARMA LTD-ADR (CANF) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CANF, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CANF, evaluating the profitability, health, valuation and growth aspects
- CAN FITE BIOPHARMA LTD-ADR (CANF) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CAN FITE BIOPHARMA LTD-ADR (CANF) Sales and EPS estimates to see what analysts future expectations are.
- CAN FITE BIOPHARMA LTD-ADR (CANF) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CAN FITE BIOPHARMA LTD-ADR (CANF) Insider and Institutional Ownership to learn about the owners and their transactions.
- CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Chart to make your own analysis
- CAN FITE BIOPHARMA LTD-ADR (CANF) Latest news and press-releases to stay up to date.
Does CAN FITE BIOPHARMA LTD-ADR (CANF) stock pay dividends?
CANF does not pay a dividend.
What is the Price/Earnings (PE) ratio of CAN FITE BIOPHARMA LTD-ADR (CANF)?
CAN FITE BIOPHARMA LTD-ADR (CANF) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).
What is the Short Interest ratio of CAN FITE BIOPHARMA LTD-ADR (CANF) stock?
The outstanding short interest for CAN FITE BIOPHARMA LTD-ADR (CANF) is 3.05% of its float. Check the ownership tab for more information on the CANF short interest.
CANF Technical Analysis
CANF Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CANF. While CANF seems to be doing ok healthwise, there are quite some concerns on its profitability.
CANF Financial Highlights
Over the last trailing twelve months CANF reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS increased by 40% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.4% | ||
| ROE | -144.96% | ||
| Debt/Equity | 0 |
CANF Forecast & Estimates
7 analysts have analysed CANF and the average price target is 6.7 USD. This implies a price increase of 960.87% is expected in the next year compared to the current price of 0.6314.